MedPath

MYLAN-LAMOTRIGINE

MYLAN-LAMOTRIGINE

Approved
DIN Number

02265494

Drug Class

Human

Market Date

Apr 1, 2005

Company
HC

Mylan Pharmaceuticals ULC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02265494
AIG Number0127134003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AX09 LAMOTRIGINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

LAMOTRIGINEActive
Strength: 25 MG
Monograph: LAMOTRIGINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.